Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of liraglutide on body weight in non-diabetic obese or overweight subjects
2008-001049-24Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Sep 2008
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in obesity, Overweight, sponsored by Novo Nordisk. Started Sep 2008; status: completed.
02
Drugs
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on 2008-001049-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001049-24.